Trademark: 87671420
Status Date
Tuesday, March 23, 2021
Registration Number
6297746
Registration Date
Tuesday, March 23, 2021
Filing Date
Friday, November 3, 2017
Published for Opposition
Tuesday, January 5, 2021
5 Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
37 Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
40 Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
41 Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
42 Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
Jul 7, 2021
Review Of Correspondence Complete - Address Updated
Jul 1, 2021
Teas Voluntary Amendment Received
Mar 23, 2021
Registered-Principal Register
Jan 5, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 5, 2021
Published For Opposition
Dec 16, 2020
Notification Of Notice Of Publication E-Mailed
Nov 30, 2020
Law Office Publication Review Completed
Nov 26, 2020
Approved For Pub - Principal Register
Nov 25, 2020
Teas/Email Correspondence Entered
Nov 24, 2020
Correspondence Received In Law Office
Nov 24, 2020
Teas Response To Office Action Received
Jul 6, 2020
Notification Of Non-Final Action E-Mailed
Jul 6, 2020
Non-Final Action E-Mailed
Jul 6, 2020
Non-Final Action Written
Jun 25, 2020
Letter Of Protest Evidence Forwarded
Feb 12, 2020
Notification Of Non-Final Action E-Mailed
Feb 12, 2020
Non-Final Action E-Mailed
Feb 12, 2020
Non-Final Action Written
Jan 28, 2020
Previous Allowance Count Withdrawn
Jan 27, 2020
Withdrawn From Pub - Senior Attorney Request
Jan 14, 2020
Approved For Pub - Principal Register
Jan 14, 2020
Teas/Email Correspondence Entered
Jan 14, 2020
Correspondence Received In Law Office
Jan 10, 2020
Teas Response To Suspension Inquiry Received
Jan 1, 2020
Assignment Of Ownership Not Updated Automatically
Nov 27, 2019
Assignment Of Ownership Not Updated Automatically
Nov 19, 2019
Notification Of Inquiry As To Suspension E-Mailed
Nov 19, 2019
Inquiry To Suspension E-Mailed
Nov 19, 2019
Suspension Inquiry Written
Nov 18, 2019
Lie Checked Susp - To Atty For Action
Oct 30, 2019
Assignment Of Ownership Not Updated Automatically
May 18, 2019
Notification Of Letter Of Suspension E-Mailed
May 18, 2019
Letter Of Suspension E-Mailed
May 18, 2019
Suspension Letter Written
May 16, 2019
Teas/Email Correspondence Entered
May 16, 2019
Correspondence Received In Law Office
May 9, 2019
Teas Response To Suspension Inquiry Received
Nov 14, 2018
Notification Of Inquiry As To Suspension E-Mailed
Nov 14, 2018
Inquiry To Suspension E-Mailed
Nov 14, 2018
Suspension Inquiry Written
May 9, 2018
Notification Of Letter Of Suspension E-Mailed
May 9, 2018
Letter Of Suspension E-Mailed
May 9, 2018
Suspension Letter Written
May 9, 2018
Teas/Email Correspondence Entered
May 9, 2018
Correspondence Received In Law Office
May 2, 2018
Assigned To Lie
Apr 24, 2018
Teas Response To Office Action Received
Feb 16, 2018
Notification Of Non-Final Action E-Mailed
Feb 16, 2018
Non-Final Action E-Mailed
Feb 16, 2018
Non-Final Action Written
Feb 14, 2018
Assigned To Examiner
Nov 14, 2017
New Application Office Supplied Data Entered In Tram
Nov 7, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
